Down-Regulation of lncRNA CKMT2-AS1 Predicts Poor Prognosis and Promotes Breast Cancer Progression
CKMT2-AS1 exerts its tumor-suppressing function in breast cancer via sequestering miR-106b-5p and modulating MECP2 expression. Its decreased levels are linked to the unfavorable prognosis, positioning CKMT2-AS1 as a prospective indicator for prognosticating breast cancer.
Authors
- X Y Li (ORCID: https://orcid.org/0009-0001-8082-2105)
- Dengfeng Xue
- Huijuan Xu
- Ruihong Hou
Institutions
- Shanxi Medical University (CN)
- Second Hospital of Shanxi Medical University (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/bctt.s545732
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00